Elkem Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Elkem wird ein jährliches Gewinn- und Umsatzwachstum von 52.6% bzw. 7.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 63.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.7% betragen.
Wichtige Informationen
52.6%
Wachstumsrate der Gewinne
63.34%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | -3.2% |
| Wachstumsrate der Einnahmen | 7.2% |
| Zukünftige Eigenkapitalrendite | 9.67% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 11 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • May 15
ELK: Equity Raise And Biocarbon Project Will Support Future Upside
Elkem's updated analyst price target has shifted from NOK 33.29 to NOK 31.34, reflecting analysts' refreshed assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations. What's in the News Elkem has filed a follow on equity offering of NOK 299.999997 million, offering 11,111,111 ordinary shares at NOK 27 per share through a rights offering (Key Developments).Narrativ-Update • Apr 25
ELK: New Three Division Structure And Workforce Cuts Will Support Upside
Analysts have made a small upward revision to Elkem's price target, moving it from NOK 33.14 to NOK 33.29. This reflects updated assumptions around revenue growth, profit margins and future P/E expectations.Narrativ-Update • Apr 10
ELK: New Three Division Structure And Cost Cuts Will Drive Upside
The analyst price target for Elkem has moved slightly higher to NOK33.14 from NOK32.83, with analysts citing adjustments in the assumed discount rate, revenue growth, profit margin, and future P/E to support the change. What's in the News Elkem is introducing a new corporate structure with three divisions: Elkem Silicon, Elkem Foundry Alloys and Elkem Carbon.Narrativ-Update • Mar 24
ELK: New Structure And Cost Cuts Will Support Future Upside
Analysts have kept their Elkem price target steady at NOK 32.83. They cite essentially unchanged assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for reaffirming their view.Narrativ-Update • Mar 10
ELK: Safety Actions And Stable Earnings Assumptions Will Support Upside Potential
Analysts have kept their fair value estimate for Elkem unchanged at NOK 32.83, with only small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, which feed into an updated price target narrative. What's in the News An extraordinary general meeting on 9 March 2026 approved an amendment to Section 4 of Elkem ASA's articles of association, confirming share capital at NOK 1,505,514,210 divided into 301,102,842 shares with a nominal value of NOK 5 each (Key Developments).Narrativ-Update • Feb 23
ELK: Safety Actions And Earnings Assumptions Will Shape A Balanced Outlook
The analyst price target for Elkem has been adjusted from NOK 31.85 to NOK 32.83. Analysts cite updated assumptions across the discount rate, revenue growth, profit margin and forward P/E as the key drivers behind this change.Narrativ-Update • Feb 09
ELK: Safety Reforms After Saint Fons Incident Will Support Upbeat Outlook
Narrative Update on Elkem Analysts have kept their fair value estimate for Elkem steady at NOK 31.85. They explain the unchanged price target by slightly adjusting their assumptions for discount rate, revenue growth, profit margin and future P/E expectations, rather than changing their overall view of the company’s valuation.Narrativ-Update • Jan 25
ELK: Safety Incident And Minor Assumption Shifts Will Shape Balanced Outlook
Analysts have raised their fair value estimate for Elkem to €31.85 from €31.80, citing small adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions. What's in the News On 22 December 2025, an explosion occurred at a pilot workshop at the Elkem Silicones site in Saint Fons, Lyon, France, resulting in one employee losing his life and three others being injured (company report).Narrativ-Update • Jan 10
ELK: Medical Materials Push And Ferrosilicon Cuts Will Shape Balanced Outlook
Analysts now estimate Elkem's fair value at €31.80 per share, slightly higher than the previous estimate of €31.00, citing small adjustments to their discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Explosion at Elkem's Saint Fons silicones pilot workshop in Lyon on 22 December 2025 resulted in one fatality and three injuries, with management cooperating with local authorities and providing psychological support to employees (Key Developments).Narrativ-Update • Dec 25
ELK: Medical Materials Expansion And Ferrosilicon Curtailments Will Shape Measured Outlook
Analysts have raised their price target on Elkem to NOK 31.00 from NOK 29.80, reflecting updated assumptions of a slightly lower discount rate but higher future earnings multiples, despite somewhat softer expectations for revenue growth and profit margins. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber engineered for wearable and diagnostic devices, combining high electrical conductivity, certified biocompatibility and enhanced process control (company announcement).Narrativ-Update • Dec 11
ELK: Medical Materials Expansion And Production Cuts Will Shape Balanced Outlook
Analysts have modestly raised their price target on Elkem to NOK 29.80, citing slightly lower perceived risk reflected in a reduced discount rate, while keeping growth, margin, and valuation assumptions broadly unchanged. What's in the News Elkem launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber designed for wearable and diagnostic devices, featuring high electrical conductivity, certified biocompatibility, and enhanced process control for precision healthcare applications (Key Developments).Narrativ-Update • Nov 27
ELK: New Medical-Grade Product Launch and Market Risks Will Shape Outlook
Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices.Narrativ-Update • Nov 13
ELK: Upcoming Medical Material Launch Will Support Increased Market Confidence
Narrative Update on Elkem: Analyst Price Target Revision Analysts have maintained their fair value estimate for Elkem at NOK 29.80. This reflects steady confidence in the company despite minor adjustments to key assumptions such as profit margin and growth projections.Narrativ-Update • Oct 29
Medical-Grade Silicone Launch and Production Cuts Will Balance Future Prospects
Analysts have raised their price target for Elkem from NOK 29.32 to NOK 29.80. This change reflects minor adjustments to their expectations for growth, discount rates, and profit margins.Narrativ-Update • Oct 15
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's analyst consensus price target has been raised from $27.92 to $29.32, reflecting analysts' expectations of slightly improved revenue growth and a lower discount rate that drives upward fair value adjustments. Valuation Changes The consensus analyst price target has increased from NOK 27.92 to NOK 29.32.Narrativ-Update • Sep 25
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's slight improvement in net profit margin has supported an upward revision of the consensus analyst price target from NOK26.40 to NOK27.92. What's in the News Elkem and NTE signed a long-term power purchase agreement for 300 GWh/year renewable power delivery (2028-2037) in Norway’s NO4 area.Analyseartikel • Sep 20
Earnings Tell The Story For Elkem ASA (OB:ELK)
With a price-to-earnings (or "P/E") ratio of 23.4x Elkem ASA ( OB:ELK ) may be sending very bearish signals at the...Analyseartikel • Jul 09
Is Now The Time To Look At Buying Elkem ASA (OB:ELK)?
While Elkem ASA ( OB:ELK ) might not have the largest market cap around , it received a lot of attention from a...Analyseartikel • Jun 17
Does Elkem (OB:ELK) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • May 07
Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings
Strong earnings weren't enough to please Elkem ASA's ( OB:ELK ) shareholders over the last week. We did some digging...Analyseartikel • Apr 29
Elkem (OB:ELK) Will Want To Turn Around Its Return Trends
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Mar 24
Is It Too Late To Consider Buying Elkem ASA (OB:ELK)?
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw a significant share price rise of 36% in the past...
Neues Narrativ • Feb 09
Carbon Capture Initiatives Will Strengthen ESG Positioning And Brand Value
Expansion in China and targeted operational improvements aim to boost EBITDA, enhancing revenue and earnings growth.Analyseartikel • Feb 05
Investors Still Aren't Entirely Convinced By Elkem ASA's (OB:ELK) Revenues Despite 26% Price Jump
The Elkem ASA ( OB:ELK ) share price has done very well over the last month, posting an excellent gain of 26%. While...Analyseartikel • Jan 23
Here's Why Elkem (OB:ELK) Is Weighed Down By Its Debt Load
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyseartikel • Dec 19
Market Still Lacking Some Conviction On Elkem ASA (OB:ELK)
You may think that with a price-to-sales (or "P/S") ratio of 0.3x Elkem ASA ( OB:ELK ) is definitely a stock worth...Analyseartikel • Nov 02
There May Be Reason For Hope In Elkem's (OB:ELK) Disappointing Earnings
Soft earnings didn't appear to concern Elkem ASA's ( OB:ELK ) shareholders over the last week. Our analysis suggests...Analyseartikel • Oct 27
Elkem ASA Just Missed EPS By 51%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Elkem ASA ( OB:ELK ), which a week ago released some disappointing...Analyseartikel • Sep 04
Little Excitement Around Elkem ASA's (OB:ELK) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.4x Elkem ASA ( OB:ELK ) is definitely a stock worth...Analyseartikel • Aug 07
The Returns On Capital At Elkem (OB:ELK) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analyseartikel • Jul 17
Elkem ASA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Elkem ASA ( OB:ELK ) investors will be delighted, with the company turning in some strong numbers with its latest...Analyseartikel • Jun 11
These 4 Measures Indicate That Elkem (OB:ELK) Is Using Debt In A Risky Way
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • May 27
Elkem ASA's (OB:ELK) Revenues Are Not Doing Enough For Some Investors
Elkem ASA's ( OB:ELK ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right now compared...Analyseartikel • May 11
Elkem ASA's (OB:ELK) Intrinsic Value Is Potentially 24% Below Its Share Price
Key Insights The projected fair value for Elkem is kr15.80 based on 2 Stage Free Cash Flow to Equity Current share...Analyseartikel • Apr 22
Analysts Have Made A Financial Statement On Elkem ASA's (OB:ELK) First-Quarter Report
Elkem ASA ( OB:ELK ) just released its latest first-quarter report and things are not looking great. It was a pretty...Analyseartikel • Apr 09
What Does Elkem ASA's (OB:ELK) Share Price Indicate?
Elkem ASA ( OB:ELK ), is not the largest company out there, but it saw a double-digit share price rise of over 10% in...Analyseartikel • Dec 15
Is Elkem (OB:ELK) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Oct 23
Why Elkem ASA (OB:ELK) Could Be Worth Watching
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw significant share price movement during recent months...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 19,409 | 1,613 | 873 | 2,579 | 4 |
| 12/31/2027 | 18,539 | 1,308 | 614 | 2,144 | 4 |
| 12/31/2026 | 16,310 | 544 | 1,307 | 2,439 | 4 |
| 3/31/2026 | 16,306 | 331 | -361 | 1,672 | N/A |
| 12/31/2025 | 16,535 | 301 | -1,183 | 1,176 | N/A |
| 9/30/2025 | 16,901 | 484 | -1,233 | 1,578 | N/A |
| 6/30/2025 | 16,980 | 699 | -1,243 | 1,702 | N/A |
| 3/31/2025 | 17,458 | 2,123 | -1,820 | 1,165 | N/A |
| 12/31/2024 | 17,810 | 2,026 | -1,368 | 2,030 | N/A |
| 9/30/2024 | 8,308 | 3,256 | -2,470 | 965 | N/A |
| 6/30/2024 | 11,900 | 2,367 | -2,320 | 1,953 | N/A |
| 3/31/2024 | 16,058 | 1,085 | -2,120 | 2,696 | N/A |
| 12/31/2023 | 21,134 | 1,999 | -2,219 | 2,769 | N/A |
| 9/30/2023 | 36,517 | 1,427 | -402 | 4,959 | N/A |
| 6/30/2023 | 39,820 | 4,929 | 1,126 | 6,081 | N/A |
| 3/31/2023 | 42,988 | 7,855 | 2,987 | 7,513 | N/A |
| 12/31/2022 | 45,017 | 9,561 | 5,101 | 9,314 | N/A |
| 9/30/2022 | 45,073 | 10,631 | 5,016 | 8,989 | N/A |
| 6/30/2022 | 42,671 | 8,956 | 4,308 | 8,191 | N/A |
| 3/31/2022 | 37,733 | 6,602 | 3,115 | 6,676 | N/A |
| 12/31/2021 | 33,083 | 4,628 | 1,647 | 4,913 | N/A |
| 9/30/2021 | 29,779 | 2,770 | 1,541 | 4,377 | N/A |
| 6/30/2021 | 26,856 | 1,294 | 800 | 3,068 | N/A |
| 3/31/2021 | 25,387 | 672 | -263 | 2,138 | N/A |
| 12/31/2020 | 24,025 | 239 | -235 | 2,111 | N/A |
| 9/30/2020 | 22,498 | 150 | -557 | 1,834 | N/A |
| 6/30/2020 | 22,260 | 460 | -583 | 2,028 | N/A |
| 3/31/2020 | 22,204 | 616 | 14 | 2,527 | N/A |
| 12/31/2019 | 22,245 | 855 | N/A | 1,839 | N/A |
| 9/30/2019 | 22,840 | 1,211 | N/A | 2,805 | N/A |
| 6/30/2019 | 23,138 | 1,921 | N/A | 3,178 | N/A |
| 3/31/2019 | 24,282 | 3,104 | N/A | 3,801 | N/A |
| 12/31/2018 | 24,968 | 3,337 | N/A | 4,460 | N/A |
| 9/30/2018 | 25,216 | 3,620 | N/A | 3,611 | N/A |
| 6/30/2018 | 24,680 | 3,077 | N/A | 3,583 | N/A |
| 3/31/2018 | 22,995 | 2,011 | N/A | 2,644 | N/A |
| 12/31/2017 | 21,133 | 1,211 | N/A | 2,256 | N/A |
| 12/31/2016 | 14,045 | 722 | N/A | 1,304 | N/A |
| 12/31/2015 | 14,361 | 809 | N/A | 1,820 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ELKDas prognostizierte Gewinnwachstum (52.6% pro Jahr) liegt über der Sparquote (3.3%).
Ertrag vs. Markt: ELKDie Erträge des Unternehmens (52.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Norwegian (9.7% pro Jahr).
Hohe Wachstumserträge: ELKEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: ELKDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Norwegian (2% pro Jahr).
Hohe Wachstumseinnahmen: ELKDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ELKDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.7%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/20 06:28 |
| Aktienkurs zum Tagesende | 2026/05/20 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Elkem ASA wird von 9 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | ABG Sundal Collier |
| Sebastian Satz | Citigroup Inc |
| Elliott Geoffrey Jones | Danske Bank |